Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Inventory (2016 - 2025)

Bio-Techne (TECH) has 17 years of Change in Inventory data on record, last reported at $1.9 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 78.23% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $22.4 million, up 36.82%, while the annual FY2025 figure was $18.1 million, 27.64% up from the prior year.
  • Change in Inventory reached $1.9 million in Q4 2025 per TECH's latest filing, down from $14.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $16.0 million in Q2 2022 and bottomed at -$173000.0 in Q1 2025.
  • Average Change in Inventory over 5 years is $5.9 million, with a median of $4.9 million recorded in 2023.
  • Peak YoY movement for Change in Inventory: surged 513.82% in 2021, then crashed 886.36% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $5.7 million in 2021, then soared by 34.24% to $7.7 million in 2022, then plummeted by 43.19% to $4.4 million in 2023, then soared by 104.27% to $8.9 million in 2024, then crashed by 78.23% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $1.9 million in Q4 2025, $14.0 million in Q3 2025, and $6.6 million in Q2 2025.